Efficacy, Safety, and Tolerability of Plovamer Acetate
Washington University is looking for people with MS to participate in a research study to evaluate the effects of Plovamer Acetate on Relapsing-Remitting MS.
We are doing this study to find out if the study drug can help people with relapsing-remitting multiple sclerosis. We will also find out if it is safe to take without causing too many side effects.
This study lasts about 40 weeks and requires several clinical visits to Washington University. In addition, five MRI scans will be done throughout the study. Study participants are randomly assigned to receive either one dose of the study drug or Glatiramer Acetate (Copaxone). The study drug is administered once weekly via subcutaneous injection.
You may qualify to participate if you:
- Are between the ages of 18-60 years old
- Have been diagnosed with Relapsing-Remitting MS
- Are able to walk without the use of assistance